AKArina V. Kerechun

Arina V. Kerechun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arina V. Kerechun has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative characteristics of prostate cancer detection by transperineal and transrectal fusion-biopsy

    by S. V. Popov, I. N. Orlov, A. V. Bashin, T. M. Topuzov, A. V. Tsoi, A. V. Kerechun

    Introduction. Prostate biopsy remains the gold standard for the diagnosis of prostate cancer. In contemporary practice, increasing preference is given to fusion biopsy, which is more reliable and informative than conventional ultrasound‑guided systematic biopsy. Fusion prostate biopsy can be performed via transrectal or transperineal access, and the superiority of one approach over the other is still under investigation. Objective. To assess and compare the diagnostic performance of transrectal versus transperineal fusion prostate biopsy for the detection of prostate cancer. Materials & methods. A comparative study was conducted between October 2024 and January 2025 at St. Luke’s Clinical Hospital, Saint Petersburg. A total of 162 men with suspected prostate cancer were enrolled. Group 1 comprised 115 patients who underwent transrectal fusion prostate biopsy. Group 2 included 47 patients who underwent transperineal fusion prostate biopsy using a stabilized technique with a stepper and stabilizer. Results. In the transrectal fusion biopsy group, prostate cancer was identified in 54 cases (46.95%) on targeted cores and in 81 cases (70.4%) on standard systematic cores. Systematic cores alone detected cancer in 44 patients (38.26%), whereas targeted cores alone did so in 5 patients (4.34%); in an additional 6 patients (5.22%), targeted cores upgraded the Gleason score. Omitting systematic sampling in transrectal fusion biopsy would have reduced overall cancer detection by 38.26%, including omission of clinically significant (aggressive) disease in 9.57% of cases. In the transperineal fusion biopsy group, cancer was detected in 31 patients (65.96%) on targeted cores and in 25 patients (53.19%) on systematic cores. Targeted cores alone identified cancer in 9 cases (19.15%), whereas systematic cores contributed only 3 additional cases (6.38%), all ISUP grade group 1. Targeted sampling led to Gleason score upgrading in 4 patients (8.51%). Conclusions. For the transperineal fusion technique, omitting systematic biopsies may reduce the number of cores without materially compromising diagnostic accuracy. In contrast, for transrectal fusion biopsy, systematic sampling remains crucial, particularly for detecting aggressive cancers and improving overall diagnostic yield. These approach‑specific differences warrant further investigation to refine diagnostic pathways for prostate cancer.

  • Robot-assisted abdominoperineal vesicourethral reanastomosis

    by Sergey V. Popov, Igor N. Orlov, Aleksey V. Tsoy, Timur M. Topuzov, Nikita Yu. Gneev, Arina V. Kerechun, Boris A. Neymark, Цой Алексей Валерьевич

    BACKGROUND: Vesicourethral anastomotic stricture is a narrowing of the urethra at the junction between the membranous urethra and the bladder neck. This complication is reported in 4.8% of patients following radical prostatectomy, with an average time to vesicourethral anastomotic stricture formation of 3.4 months. Minimally invasive treatment modalities, such as urethral dilation, transurethral resection, and bladder neck incision, are frequently ineffective. Reconstructive surgery is currently considered the treatment of choice for recurrent vesicourethral anastomotic stricture. According to various authors, success rates of vesicourethral anastomotic reconstruction using perineal, abdominal, or abdominoperineal approaches can reach up to 100%. AIM: The work aimed to evaluate the outcomes of robot-assisted abdominoperineal vesicourethral reanastomosis in patients with recurrent vesicourethral anastomotic stricture. METHODS: The study analyzed treatment outcomes in seven patients with recurrent vesicourethral anastomotic stricture who underwent robot-assisted abdominoperineal vesicourethral reanastomosis. RESULTS: Six months postoperatively, there was a significant improvement in urinary outflow: Qmax increased from 1.8 [0; 3.6] at baseline to 13.4 [12.2; 14] mL/s, p = 0.0005. Furthermore, there was a marked reduction in lower urinary tract symptoms, with the total IPSS score decreasing from 23 [20.3; 25.8] to 9 [7.5; 11] (p = 0.0234), and an improvement in quality of life: QoL decreased from 6 [5; 6] to 2 [2; 2.5] (p = 0.0156). No patient experienced complications above Clavien–Dindo grade II. One (14.3%) patient developed de novo severe urinary incontinence, whereas two (28.6%) had persistent mild incontinence that existed prior to surgery. There were no additional interventions required during the postoperative period. CONCLUSION: Robot-assisted abdominoperineal vesicourethral reanastomosis is a safe and effective technique for the management of recurrent vesicourethral anastomotic stricture. This approach may be considered for patients with preserved continence and extensive strictures. Further studies are needed to assess long-term surgical outcomes.

  • Open Access

    COMPLICATIONS OF TRANSPERINEAL VS. TRANSRECTAL BIOPSY IN PROSTATE CANCE DIAGNOSIS: A COMPARATIVE ANALYSIS

    by St. Petersburg St. Luke'S Clinical Hospital, Sergey V. Popov, Timur M. Topuzov, Andrey V. Bashin, Boris A. Neymark, Aleksey V. Tsoi, Nikita Yu. Gneev, Arina V. Kerechun

    Objective. The purpose of the study is to perform a comparative analysis of the frequency and nature of adverse events occurring during transrectal and transperineal fusion biopsy of the prostate gland, with a particular focus on infectious, hemorrhagic and urodynamic complications, as well as to assess the clinical significance of complications and their potential impact on the choice of access method. Materials and Methods. The study included data from 323 patients with suspected prostate cancer who underwent transrectal or transperineal fusion prostate biopsy. The age of the patients ranged from 46 to 79 years, with a mean age of 65.07±5.58 years. Results. The study demonstrates that the incidence of adverse events in transrectal and transperineal fusion prostate biopsies differs primarily due to infectious and inflammatory complications. Infectious complications were recorded exclusively in the transrectal access group (3.78%), while they were not observed at all in transperineal biopsy (p=0.0394), indicating the potential advantage of this method in terms of infectious safety. There were no cases of haematoma, urethral bleeding, or rectal bleeding. Acute urinary retention was rare and occurred with equally low frequency in both groups.